Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 18 | 2024 | 1158 | 3.440 |
Why?
|
Sarcoma | 14 | 2023 | 1800 | 2.730 |
Why?
|
Bone Neoplasms | 17 | 2023 | 2527 | 2.120 |
Why?
|
Sarcoma, Synovial | 4 | 2023 | 153 | 1.650 |
Why?
|
Pleural Effusion | 3 | 2021 | 341 | 1.510 |
Why?
|
Cytodiagnosis | 5 | 2024 | 447 | 1.330 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2024 | 1605 | 1.220 |
Why?
|
Osteosarcoma | 6 | 2023 | 896 | 1.050 |
Why?
|
Cyst Fluid | 2 | 2018 | 83 | 1.030 |
Why?
|
Biopsy, Fine-Needle | 10 | 2024 | 1118 | 0.930 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.890 |
Why?
|
Pancreatic Cyst | 3 | 2018 | 367 | 0.870 |
Why?
|
Fibromatosis, Aggressive | 1 | 2024 | 126 | 0.830 |
Why?
|
Synovial Cyst | 2 | 2022 | 34 | 0.800 |
Why?
|
Abdominal Fat | 1 | 2024 | 221 | 0.790 |
Why?
|
Fibroma, Ossifying | 1 | 2021 | 14 | 0.780 |
Why?
|
Immunohistochemistry | 11 | 2024 | 11067 | 0.760 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2021 | 53 | 0.750 |
Why?
|
RNA-Binding Protein EWS | 6 | 2024 | 210 | 0.750 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 374 | 0.740 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2024 | 3634 | 0.730 |
Why?
|
Chordoma | 6 | 2020 | 347 | 0.710 |
Why?
|
Pleural Effusion, Malignant | 1 | 2021 | 106 | 0.700 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2020 | 54 | 0.670 |
Why?
|
Ascitic Fluid | 1 | 2019 | 189 | 0.660 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.650 |
Why?
|
beta Catenin | 1 | 2024 | 1042 | 0.630 |
Why?
|
Body Fluids | 1 | 2019 | 320 | 0.590 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.580 |
Why?
|
Amyloidosis | 2 | 2024 | 865 | 0.560 |
Why?
|
In Situ Hybridization | 6 | 2021 | 1900 | 0.560 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2017 | 133 | 0.530 |
Why?
|
Sarcoma, Small Cell | 1 | 2016 | 17 | 0.520 |
Why?
|
Adenocarcinoma | 4 | 2023 | 6341 | 0.510 |
Why?
|
Mucin-4 | 1 | 2014 | 33 | 0.490 |
Why?
|
Lung Transplantation | 1 | 2024 | 1307 | 0.470 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5366 | 0.470 |
Why?
|
Fasciitis | 1 | 2014 | 67 | 0.440 |
Why?
|
Diagnosis, Differential | 11 | 2024 | 12976 | 0.430 |
Why?
|
Liposarcoma | 3 | 2020 | 289 | 0.410 |
Why?
|
Joint Diseases | 1 | 2016 | 460 | 0.400 |
Why?
|
Preoperative Period | 1 | 2014 | 551 | 0.390 |
Why?
|
Pancreas | 2 | 2020 | 1684 | 0.390 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 915 | 0.380 |
Why?
|
Sciatic Nerve | 1 | 2014 | 618 | 0.370 |
Why?
|
Calcinosis | 4 | 2022 | 1477 | 0.360 |
Why?
|
Spine | 1 | 2018 | 1129 | 0.360 |
Why?
|
Splenic Neoplasms | 1 | 2010 | 94 | 0.340 |
Why?
|
Epithelioid Cells | 3 | 2020 | 60 | 0.340 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2022 | 156 | 0.340 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2022 | 118 | 0.330 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2010 | 82 | 0.330 |
Why?
|
Pathology, Clinical | 1 | 2013 | 376 | 0.330 |
Why?
|
Neurilemmoma | 1 | 2015 | 523 | 0.330 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 215 | 0.320 |
Why?
|
Gene Rearrangement | 5 | 2020 | 1125 | 0.320 |
Why?
|
RANK Ligand | 2 | 2020 | 318 | 0.300 |
Why?
|
Humans | 82 | 2024 | 761208 | 0.300 |
Why?
|
Skull Neoplasms | 2 | 2019 | 173 | 0.300 |
Why?
|
Middle Aged | 44 | 2024 | 220853 | 0.290 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58952 | 0.290 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 791 | 0.290 |
Why?
|
Adenoma | 2 | 2009 | 2159 | 0.290 |
Why?
|
Aged | 34 | 2024 | 169288 | 0.290 |
Why?
|
Knee Joint | 1 | 2016 | 1678 | 0.290 |
Why?
|
Fibrosarcoma | 2 | 2023 | 308 | 0.290 |
Why?
|
Male | 49 | 2024 | 360693 | 0.290 |
Why?
|
Chondrosarcoma | 2 | 2023 | 295 | 0.280 |
Why?
|
Adult | 40 | 2024 | 221119 | 0.280 |
Why?
|
Female | 48 | 2024 | 392544 | 0.260 |
Why?
|
Endometrial Neoplasms | 2 | 2018 | 1366 | 0.260 |
Why?
|
Cell Nucleus | 1 | 2015 | 2881 | 0.260 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2009 | 323 | 0.260 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13385 | 0.250 |
Why?
|
Gastroplasty | 1 | 2007 | 157 | 0.250 |
Why?
|
Staining and Labeling | 3 | 2024 | 1080 | 0.240 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4909 | 0.240 |
Why?
|
Young Adult | 19 | 2024 | 59221 | 0.240 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.230 |
Why?
|
Fibroma | 2 | 2018 | 190 | 0.230 |
Why?
|
Congo Red | 1 | 2024 | 48 | 0.230 |
Why?
|
Observer Variation | 2 | 2024 | 2610 | 0.220 |
Why?
|
Cyclin D1 | 1 | 2024 | 451 | 0.200 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1265 | 0.200 |
Why?
|
Granuloma, Giant Cell | 1 | 2021 | 32 | 0.200 |
Why?
|
Prognosis | 11 | 2023 | 29687 | 0.200 |
Why?
|
Lymph Nodes | 1 | 2013 | 3461 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.190 |
Why?
|
Clone Cells | 2 | 2022 | 1668 | 0.190 |
Why?
|
Giant Cells | 1 | 2021 | 188 | 0.190 |
Why?
|
Chondroblastoma | 1 | 2020 | 47 | 0.180 |
Why?
|
Artifacts | 1 | 2009 | 1912 | 0.180 |
Why?
|
Thyroid Neoplasms | 2 | 2015 | 2330 | 0.180 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1304 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 367 | 0.170 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
STAT6 Transcription Factor | 1 | 2020 | 196 | 0.170 |
Why?
|
Adolescent | 16 | 2024 | 88298 | 0.170 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 104 | 0.170 |
Why?
|
Protein Isoforms | 1 | 2024 | 1695 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8530 | 0.170 |
Why?
|
Fibroma, Desmoplastic | 1 | 2019 | 6 | 0.160 |
Why?
|
Neurofibrosarcoma | 1 | 2019 | 27 | 0.160 |
Why?
|
Exudates and Transudates | 1 | 2019 | 174 | 0.160 |
Why?
|
Amyloid | 1 | 2024 | 848 | 0.160 |
Why?
|
Hemangioma | 1 | 2023 | 727 | 0.150 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 80 | 0.150 |
Why?
|
Limb Salvage | 1 | 2021 | 480 | 0.150 |
Why?
|
Chromatin | 4 | 2024 | 2946 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 208 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4021 | 0.150 |
Why?
|
Clinical Competence | 1 | 2013 | 4788 | 0.140 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2018 | 93 | 0.140 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 305 | 0.140 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 220 | 0.140 |
Why?
|
Biopsy, Needle | 2 | 2019 | 1624 | 0.140 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2018 | 36415 | 0.140 |
Why?
|
Central Cord Syndrome | 1 | 2016 | 5 | 0.140 |
Why?
|
Interferons | 1 | 2020 | 702 | 0.140 |
Why?
|
Retrospective Studies | 13 | 2024 | 80674 | 0.140 |
Why?
|
Neoplasms | 3 | 2022 | 22140 | 0.140 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1457 | 0.140 |
Why?
|
Otitis Media | 1 | 2018 | 286 | 0.130 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 634 | 0.130 |
Why?
|
Hand Bones | 1 | 2016 | 13 | 0.130 |
Why?
|
Curettage | 1 | 2016 | 74 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.130 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2016 | 43 | 0.130 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14675 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2915 | 0.130 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6819 | 0.130 |
Why?
|
Immunoenzyme Techniques | 2 | 2016 | 1703 | 0.130 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2017 | 170 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.130 |
Why?
|
Radius | 1 | 2019 | 442 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 83 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9278 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2020 | 811 | 0.120 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 170 | 0.120 |
Why?
|
Melanoma | 1 | 2013 | 5694 | 0.120 |
Why?
|
Fatal Outcome | 3 | 2018 | 1838 | 0.120 |
Why?
|
Temporal Bone | 1 | 2018 | 683 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Lung | 3 | 2022 | 9979 | 0.110 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 609 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2509 | 0.110 |
Why?
|
Child | 11 | 2024 | 80152 | 0.110 |
Why?
|
Acromioclavicular Joint | 1 | 2013 | 78 | 0.100 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2813 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2872 | 0.100 |
Why?
|
Histones | 2 | 2020 | 2570 | 0.100 |
Why?
|
RNA, Viral | 1 | 2021 | 2839 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1089 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2024 | 3313 | 0.100 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 993 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1545 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1855 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 549 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2413 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 703 | 0.090 |
Why?
|
Tendinopathy | 1 | 2013 | 173 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2142 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11119 | 0.090 |
Why?
|
Osteoblasts | 1 | 2016 | 1144 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3726 | 0.090 |
Why?
|
Bone and Bones | 2 | 2022 | 2568 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1031 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2067 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2112 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10088 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2021 | 64681 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 938 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1155 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2974 | 0.070 |
Why?
|
Child, Preschool | 6 | 2019 | 42224 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20119 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3788 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2013 | 1120 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2018 | 20588 | 0.070 |
Why?
|
Autopsy | 2 | 2021 | 1010 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2024 | 0.070 |
Why?
|
Immunotherapy | 1 | 2022 | 4642 | 0.070 |
Why?
|
Oncogenes | 2 | 2022 | 1220 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 16952 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3770 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4384 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2007 | 15637 | 0.060 |
Why?
|
Infant | 4 | 2019 | 36169 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2018 | 2894 | 0.060 |
Why?
|
Epithelial Cells | 2 | 2020 | 3671 | 0.060 |
Why?
|
Cohort Studies | 2 | 2019 | 41496 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4137 | 0.060 |
Why?
|
Survival Rate | 4 | 2021 | 12728 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2024 | 184 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2330 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3758 | 0.050 |
Why?
|
Binding Sites | 2 | 2023 | 5988 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6585 | 0.050 |
Why?
|
Mediastinum | 1 | 2023 | 267 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4744 | 0.050 |
Why?
|
Coloring Agents | 1 | 2024 | 561 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3590 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13632 | 0.040 |
Why?
|
Desmin | 1 | 2020 | 99 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39126 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8837 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 150 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 651 | 0.040 |
Why?
|
Contrast Media | 3 | 2017 | 5311 | 0.040 |
Why?
|
Muscle Cells | 1 | 2020 | 195 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2023 | 11509 | 0.040 |
Why?
|
Florida | 1 | 2020 | 429 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 309 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1610 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 329 | 0.040 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2827 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 233 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4242 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 579 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 317 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2019 | 473 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 569 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 559 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2015 | 6124 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 696 | 0.030 |
Why?
|
Pinch Strength | 1 | 2016 | 4 | 0.030 |
Why?
|
Fibula | 1 | 2019 | 266 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2683 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6486 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 716 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1277 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
Gene Fusion | 1 | 2019 | 355 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3592 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 2018 | 247 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 774 | 0.030 |
Why?
|
Iopamidol | 1 | 2016 | 186 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1743 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 268 | 0.030 |
Why?
|
Laminectomy | 1 | 2016 | 225 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2019 | 570 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1958 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 592 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 996 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 744 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1386 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1112 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2522 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 741 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
Myocarditis | 1 | 2021 | 792 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2913 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 958 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.030 |
Why?
|
Actins | 1 | 2020 | 2046 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2022 | 1530 | 0.030 |
Why?
|
Shoulder Pain | 1 | 2013 | 151 | 0.030 |
Why?
|
Extremities | 1 | 2018 | 867 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6312 | 0.030 |
Why?
|
Electromyography | 1 | 2017 | 1393 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16575 | 0.020 |
Why?
|
Postural Balance | 1 | 2016 | 623 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2444 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2658 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3328 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2011 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 748 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3551 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1453 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2024 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2016 | 976 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1892 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1270 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2709 | 0.020 |
Why?
|
Radiotherapy | 1 | 2015 | 1499 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2820 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9297 | 0.020 |
Why?
|
Accidental Falls | 1 | 2016 | 1068 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5006 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4190 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4746 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17897 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6387 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5032 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9327 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3512 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6781 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5753 | 0.020 |
Why?
|
Anticoagulants | 1 | 2021 | 4795 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81326 | 0.020 |
Why?
|
DNA | 1 | 2019 | 7189 | 0.020 |
Why?
|
Mutation | 2 | 2020 | 30002 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9416 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10422 | 0.010 |
Why?
|
Glucose | 1 | 2015 | 4342 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3163 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9566 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4052 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4251 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3594 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7571 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12474 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168079 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15920 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39957 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12747 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15721 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74239 | 0.010 |
Why?
|
United States | 1 | 2016 | 72339 | 0.000 |
Why?
|